KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cvs Health (CVS) Interest Expenses (2016 - 2025)

Cvs Health's Interest Expenses history spans 14 years, with the latest figure at $787.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 3.83% year-over-year to $787.0 million, compared with a TTM value of $3.1 billion through Dec 2025, up 5.44%, and an annual FY2025 reading of $3.1 billion, up 5.44% over the prior year.
  • Interest Expenses for Q4 2025 was $787.0 million at Cvs Health, roughly flat from $784.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $787.0 million in Q4 2025, with the low at $552.0 million in Q4 2022.
  • Average Interest Expenses over 5 years is $676.2 million, with a median of $688.0 million recorded in 2023.
  • Year-over-year, Interest Expenses dropped 17.65% in 2021 and then increased 25.0% in 2023.
  • Tracing CVS's Interest Expenses over 5 years: stood at $608.0 million in 2021, then fell by 9.21% to $552.0 million in 2022, then increased by 25.0% to $690.0 million in 2023, then grew by 9.86% to $758.0 million in 2024, then increased by 3.83% to $787.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Interest Expenses are $787.0 million (Q4 2025), $784.0 million (Q3 2025), and $763.0 million (Q2 2025).